Skip to content

mHealth Biometrics for Sedentary People (MotivateLJMU)

Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04979702
Enrollment
86
Registered
2021-07-28
Start date
2020-08-01
Completion date
2022-07-01
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The investigators aim to undertake a feasibility randomised controlled trial (RCT) to investigate whether mHealth technology, allowing biometric informed feedback and coaching on exercise and PA, can be effective in previously sedentary individuals. The overall objective is to have an evidence-based exercise and PA intervention ready to evaluate in a future RCT.

Detailed description

Participants will be recruited from Liverpool John Moores University, and other local office-based businesses. Participants will be randomised to either online exercise resources only (n=50) or exercise counselling + mHealth (n=50).This is a pilot parallel group, randomised controlled trial whereby consenting participants will complete baseline testing (T1) before starting a 12-week exercise intervention supported by online resources only (online resources intervention) or online resources and a programme of exercise counselling enhanced with mobile health (mHealth) technology (mHealth intervention). Participants will repeat baseline assessments (i) 6-weeks into the intervention (T2) and, (ii) immediately post-intervention (T3). Testing at baseline and following the 12-week intervention will include changes in physical activity, blood pressure, body composition and glycaemia control (n=20). Both groups will have access to online resources throughout the 12-week programme. The intervention group will be provided with exercise counselling and to support this they will also be provide with a wristwatch that can monitor everyday activity and their heart rate, a smartphone app and access to a website. The intervention group will also participate in 4 consultations with an exercise specialist to plan their exercise programme and be updated on their progress towards physical activity targets. Weekly text message updates will also provide feedback to the intervention group with participants able to respond to these updates.

Interventions

BEHAVIORALActive Control

Participants will complete a 3-month exercise and physical activity intervention supported by online recourses

Participants will complete a 3-month exercise and physical activity intervention supported by online recourses, exercise counselling sessions and mHealth technology

Sponsors

Liverpool John Moores University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

No masking

Intervention model description

Randomised controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Aged 18-75 * No known cardiovascular or metabolic disorder (e.g. heart failure, diabetes, previous myocardial infarction etc.) * Able to exercise safely as deemed by completion of the PAR-Q+. * Not currently meeting the recommended exercise guidelines (150 minutes moderate or 75 minutes of vigorous intensity physical activity per week), as assessed during screening questions related to the participants previous activity levels.

Exclusion criteria

* Aged \<18 or \>75 * Pregnancy or planning to become pregnant in the next 3 months * \<6 months postpartum or stopped breastfeeding \<1 month before recruitment * Not owning a smartphone with a data plan or access to WiFi

Design outcomes

Primary

MeasureTime frameDescription
Device derived adherence to structured exerciseThrough study completion, an average 12 weeksNumber of exercise sessions per week
Device derived duration to structured exerciseThrough study completion, an average 12 weeksminutes of exercise completed per session
Device derived intensity of structured exerciseThrough study completion, an average 12 weeksintensity of exercise sessions performed (% of HR max)
Change in Device derived physical activity (GENEActiv)Baseline, Mid intervention (Week 6-7), the final 2 weeks of intervention period (weeks 10-12).minutes of Moderate and Vigorous physical activity
Change in Survey reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ))Baseline, 4, 6, 8 12 weeksBouts of mild, moderate and strenuous exercise lasting ≥30 minutes

Secondary

MeasureTime frameDescription
Glycaemic controlBaseline and immediately following intervention (12 weeks)Flash glucose monitoring
Patient qualitative survey on intervention acceptabilityImmediately following intervention (12 weeks)Study specific questionnaire (qualitative data)
Patient qualitative survey on testing acceptability7 Days following baseline testingStudy specific questionnaire (qualitative data)
HeightBaseline, 6-weeks and immediately following intervention (12 weeks)Height (m)
12-Item Short Form SurveyBaseline, Mid (week 6) and post (week 12)SF-12 Questionnaire (max 44 min 8, high score mean better outcome)
Patient Interview to access intervention acceptabilityWithin 2 weeks of the end of the interventionPatient interview
Patient Interview to access testing acceptabilityWithin 2 weeks of the baseline testingPatient interview
Exercise motivationBaseline, Mid (week 6) and post (week 12)Behavioural regulation in exercise questionnaire-2 (BREQ-2). Max score 76, min score 0, high score is better
WeightBaseline, 6-weeks and immediately following intervention (12 weeks)Weight (kg)
Waist CircumferenceBaseline, 6-weeks and immediately following intervention (12 weeks)Waist Circumference (cm)
Concentration of Hba1cBaseline and immediately following intervention (12 weeks)Hba1c
Blood Lipid concentrationsBaseline and immediately following intervention (12 weeks)Total cholesterol, HDL/LDL, Triglycerides

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026